Holding(s) in Company
October 12 2007 - 5:44AM
UK Regulatory
RNS Number:6211F
Celoxica Holdings PLC
12 October 2007
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to
which voting rights are attached
CELOXICA HOLDINGS PLC
2. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights (X)
An acquisition or disposal of financial instruments which may ( )
result in the acquisition of shares already issued to which
voting rights are attached
An event changing the breakdown of voting rights ( )
Other (specify): ( )
3. Full name of person(s) subject to the notification obligation:
Advent Venture Partners LLP
4. Full name of shareholder(s) (if different from 3.)
(NB abbreviation noted in brackets)
Advent Private Equity Fund III 'A' (APEF3A);
Advent Private Equity Fund III 'B' (APEF3B);
Advent Private Equity Fund III 'C' (APEF3C);
Advent Private Equity Fund III 'D' (APEF3D);
Advent Private Equity Fund III GmbH & Co KG (APEF3KG);
Advent Private Equity Fund III Affiliates (APEF3Aff);
Advent Management III Limited Partnership (AM3LP)
5. Date of the transaction (and date on which the threshold is crossed
or reached if different):
10 Oct 2007
6. Date on which issuer notified:
11 Oct 2007
7. Threshold(s) that is/are crossed or reached:
24 %
8. Notified details:
A. Voting rights attached to shares
Class/type of shares (if possible using the Ordinary (GB00B0L9TZ33)
ISIN code)
Situation previous to Resulting situation after the triggering transaction
the triggering
transaction
Number of Number Number Number of voting % of voting rights
Shares of of rights
Voting shares
Rights
Direct Direct Indirect Direct Indirect
20,735,553* 20,735,553* 24.594%*
*: comprised *: comprised *: comprised
of of of:
APEF3A: APEF3A: APEF3A:
10,492,939 10,492,939 12.446%
APEF3B: APEF3B: APEF3B:
5,141,609 5,141,609 6.099%
APEF3C:
1,434,234 APEF3C: APEF3C:
1,434,234 1.701%
APEF3D:
2,821,118 APEF3D: APEF3D:
2,821,118 3.346%
APEF3KG: APEF3KG: APEF3KG:
405,914 405,914 0.481%
APEF3Aff: APEF3Aff: APEF3Aff:
338,263 338,263 0.401%
AM3LP: AM3LP: AM3LP:
101,476 101,476 0.120%
B. Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period/ rights that may rights
instrument Date be acquired if
the instrument is
exercised/
converted
n/a
Total (A+B)
Number of voting rights % of voting rights
Refer A above
9. Chain of controlled undertakings through which the voting rights and/
or the financial instruments are effectively held, if applicable:
Advent Venture Partners LLP owns 100% of Advent Limited. Advent
Limited owns 100% of Advent Private Equity GmbH, which is the general
partner of Advent Private Equity Fund III GMBH & CO KG. Advent
Limited also owns 100% of Advent Management III Limited, which is the
general partner of Advent Management III Limited Partnership, which
is general partner of each of Advent Private Equity Fund III 'A'
Limited Partnership, Advent Private Equity Fund III 'B' Limited
Partnership, Advent Private Equity Fund III 'C' Limited Partnership,
Advent Private Equity Fund III 'D' Limited Partnership and Advent
Private Equity Fund III Affiliates Limited Partnership.
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy
holder will cease to hold:
12. Date on which proxy holder
will cease to hold voting
rights:
13. Additional information:
14: Contact name: Leslie Gabb, Finance Partner
15. Contact telephone number: +44 20 7932 2100
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGUGPCUUPMGUP
Celoxica (LSE:CXA)
Historical Stock Chart
From May 2024 to Jun 2024
Celoxica (LSE:CXA)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Celoxica (London Stock Exchange): 0 recent articles
More Celoxica Holdings News Articles